PubRank

O Bruserud

Author PubWeight™ 25.55‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 [A management program for primary thrombocytopenia]. Tidsskr Nor Laegeforen 1999 1.38
2 Review: genetic models of acute myeloid leukaemia. Oncogene 2008 1.14
3 Synergistic induction of p53 mediated apoptosis by valproic acid and nutlin-3 in acute myeloid leukemia. Leukemia 2011 1.11
4 Heat shock protein 90 - a potential target in the treatment of human acute myelogenous leukemia. Curr Cancer Drug Targets 2009 1.02
5 Animal models of acute myelogenous leukaemia - development, application and future perspectives. Leukemia 2005 0.99
6 Cyclic AMP can promote APL progression and protect myeloid leukemia cells against anthracycline-induced apoptosis. Cell Death Dis 2013 0.89
7 Specific cellular signal-transduction responses to in vivo combination therapy with ATRA, valproic acid and theophylline in acute myeloid leukemia. Blood Cancer J 2011 0.87
8 Insulin-like growth factor-1 (IGF-1) has a costimulatory effect on proliferation of committed progenitors derived from human umbilical cord CD34+ cells. Stem Cells 1998 0.85
9 Large-volume leukapheresis yields more viable CD34+ cells and colony-forming units than normal-volume leukapheresis, especially in patients who mobilize low numbers of CD34+ cells. Transfusion 2005 0.84
10 Identification of four SB antigens by cloned cells. Population studies of Norwegians. Tissue Antigens 1983 0.83
11 BCR/ABL leukemia oncogene fusion peptides selectively bind to certain HLA-DR alleles and can be recognized by T cells found at low frequency in the repertoire of normal donors. Blood 1996 0.82
12 No differences in colony formation of peripheral blood stem cells frozen with 5% or 10% dimethyl sulfoxide. J Hematother Stem Cell Res 2003 0.82
13 HLA-DR3 and -DR4 control T-lymphocyte responses to mumps and Coxsackie B4 virus: studies on patients with type 1 (insulin-dependent) diabetes and healthy subjects. Diabetologia 1985 0.82
14 Ribosomal proteins sustain morphology, function and phenotype in acute myeloid leukemia blasts. Leuk Res 1998 0.81
15 In vitro effects of insulin-like growth factor-1 (IGF-1) on proliferation and constitutive cytokine secretion by acute myelogenous leukemia blasts. Eur J Haematol 1999 0.81
16 T lymphocyte responses to Coxsackie B4 and mumps virus. I. Influence of HLA-DR restriction elements. Tissue Antigens 1985 0.80
17 Interleukin 2- and interferon-production and expression of interleukin 2 receptors by human mononuclear cells stimulated with mumps virus or phytohaemagglutinin. Acta Pathol Microbiol Immunol Scand C 1986 0.79
18 Relative roles of natural killer- and T cell-mediated anti-leukemia effects in chronic myelogenous leukemia patients treated with interferon-alpha. Leuk Lymphoma 1995 0.79
19 The role of the CD8-positive subset of T cells in proliferative responses to soluble antigens. I. Studies of healthy subjects, type 1 diabetics, and coeliac disease patients. Scand J Immunol 1986 0.79
20 Autologous transplantation: the viable transplanted CD34+ cell dose measured post-thaw does not predict engraftment kinetics better than the total CD34+ cell dose measured pre-freeze in patients that receive more than 2x10(6) CD34+ cells/kg. Cytotherapy 2004 0.78
21 Circadian variations do not have a major impact on serum levels of soluble (S) L-selectin (CD63L), S-intercellular adhesion molecule 1 (sICAM-1/CD54) and thrombopoietin in healthy individuals. Scand J Clin Lab Invest 2002 0.78
22 T lymphocyte responses to Coxsackie B4 and mumps virus. II. Immunoregulation by HLA-DR3 and -DR4 associated restriction elements. Tissue Antigens 1985 0.77
23 HLA control of the proliferative T lymphocyte response to antigenic determinants on mumps virus. Studies of healthy individuals and patients with type 1 diabetes. Scand J Immunol 1985 0.77
24 The proliferative T-lymphocyte response to streptokinase. J Clin Lab Immunol 1986 0.76
25 Genomic HLA-DQ beta polymorphism associated with insulin-dependent diabetes mellitus. Analysis of possible functional significance. Scand J Immunol 1987 0.76
26 Tumor-specific antigens revisited: presentation to the immune system of fusion peptides resulting solely from tumor-specific chromosomal translocations. Oncol Res 1992 0.76
27 Serum thrombopoietin levels in acute leukemia patients with chemotherapy-induced cytopenia--inverse correlation between serum levels and platelet counts. Leukemia 1998 0.75
28 Serum levels of soluble ICAM-1 in acute leukemia patients with chemotherapy-induced neutropenia. Leukemia 1997 0.75
29 Can dipyridamole or verapamil slow regrowth of leukaemia cells? Leuk Res 1992 0.75
30 High dose ara-C combined with autologous peripheral blood stem cell transplantation in the treatment of acute myelogenous leukemia: the question is still not answered. Stem Cells 2000 0.75
31 [Cyclosporin A. Inhibitory effect on T lymphocytes]. Tidsskr Nor Laegeforen 1986 0.75
32 [The medical leech--Hirudo medicinalis. Natural occurrence, medical use and complications]. Tidsskr Nor Laegeforen 1987 0.75
33 The role of the CD8-positive subset of T cells in proliferative responses to soluble antigens. II. CD8-positive cells are not responsible for DR-associated differences in responsiveness to mumps and Coxsackie B4. Scand J Immunol 1986 0.75
34 [Treatment with high-dose cytostatic agents]. Tidsskr Nor Laegeforen 1994 0.75
35 Sudden death caused by heart block in a patient with multiple myeloma and cardiac amyloidosis. Acta Med Scand 1988 0.75
36 The effect of disodium cromoglycate on in vitro proliferation of peripheral blood mononuclear cells from allergic and healthy donors. Scand J Immunol 1992 0.75
37 [The genetic background of type I (insulin-dependent) diabetes mellitus]. Tidsskr Nor Laegeforen 1986 0.75
38 Dipyridamol inhibits activation of human T lymphocytes in vitro. Clin Immunol Immunopathol 1987 0.75
39 [The cellular immune system. Possible adverse effects of drugs]. Tidsskr Nor Laegeforen 1986 0.75
40 [Immunology and malnutrition. Medical and social problems in developing countries]. Tidsskr Nor Laegeforen 1986 0.75
41 The effect of theophyllamine on T-lymphocyte activation in vitro. Clin Immunol Immunopathol 1984 0.75
42 [Fever of unknown origin in adults with malignant diseases]. Tidsskr Nor Laegeforen 1983 0.75
43 Reduction of coronary artery bypass graft occlusion by dipyridamol--is immunosuppression important? Clin Immunol Immunopathol 1988 0.75
44 Functional differentiation of acute myeloid leukaemia blast cells. APMIS 1999 0.75
45 Studies on the HLA association to insulin-dependent diabetes mellitus (IDDM). Pol Arch Med Wewn 1990 0.75
46 Production of interleukin 2 containing growth medium for cloning of human T lymphocytes. J Immunol Methods 1984 0.75
47 [High-dose therapy with autologous stem cell support in malignant diseases]. Tidsskr Nor Laegeforen 1994 0.75
48 Cytotoxic and proliferative functions of T lymphocyte clones derived very shortly after allogeneic bone marrow transplantation. Bone Marrow Transplant 1991 0.75
49 Effect of verapamil on T-lymphocyte activation in vitro. Scand J Immunol 1985 0.75
50 [Large granular lymphocytic leukemia]. Tidsskr Nor Laegeforen 1998 0.75
51 [Hyperosmolar nonketotic diabetic coma]. Tidsskr Nor Laegeforen 1983 0.75